Teva and Xenon provide update on TV-45070 Phase 2b study in osteoarthritis pain
1 July 2015 | By Victoria White
Teva and Xenon have reported top line results from a Phase 2b study designed to evaluate the safety and efficacy of TV-45070 in patients with osteoarthritis...